Or call 888-224-2480 for fastest service.

You can save extra 10% off the current rate by using code D10-999-JDS24.

Hosted by American Conference Institute, the 20^th Annual Paragraph IV Disputes & the 40th Anniversary of the Hatch-Waxman Act returns for another exciting year with curated programming that will take a retrospective look at the impactful court cases, pivotal legislation, and industry shifts that have defined the patent endgame and the pursuit of profits. Attend the only forum which shapes the law, policy, and proceedings of Paragraph IV litigation.

Join ACI as they take a retrospective look at the impactful court cases, pivotal legislation, and industry shifts that have defined the patent endgame and the pursuit of profits. As we cast our gaze forward and consider the future of Paragraph IV litigation in an evolving legal and regulatory landscape, we also reflect on the journey thus far. Now is the time to strategize for the road ahead, ensuring that every pharmaceutical IP attorney is equipped for the changes to come.

DISTINGUSIHED CHAIRS

Leaders from brand-name and generic drug companies alike acknowledge the unmatched value of the conference – the only event that caters to all sides of the industry with critical legal insights and strategic economic takeaways. ACI covers the most pressing matters – but also contextualizes them within the entire patent lifecycle under Hatch-Waxman, from pre-suit considerations to case filings and final adjudication.

MEMBERS OF THE JUDICIARY

Esteemed Judges from the federal judiciary and the USPTO’s PTAB, alongside representatives from the FTC and FDA, have graced the forums and will be present at this anniversary event providing invaluable perspectives that bridge the gap between legal theory and business realities.

Save 10% off the current registration fee by using code D10-999-JDS24.

*Discount is valid for new registrations only and it’s not applicable for workshops.